Get the Stockscreener App
2.76
7.69%
-0.23
After Hours:
2.76
Cumberland Pharmaceuticals Inc stock is traded at $2.76, with a volume of 155.57K.
It is down -7.69% in the last 24 hours and down -11.82% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$2.99
Open:
$2.96
24h Volume:
155.57K
Relative Volume:
3.48
Market Cap:
$41.29M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-3.7808
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
-13.48%
1M Performance:
-11.82%
6M Performance:
-38.67%
1Y Performance:
+146.43%
1-Day Range:
$2.64
$2.99
1-Week Range:
$2.64
$3.40
52-Week Range:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
2525 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
2.76 | 44.73M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
How to forecast Cumberland Pharmaceuticals Inc. trends using time series2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com
Has Cumberland Pharmaceuticals Inc. formed a bullish divergenceGlobal Markets & Risk Controlled Daily Plans - newser.com
Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidanceMarket Activity Summary & AI Driven Stock Price Forecasts - newser.com
[Form 4] CUMBERLAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Visual analytics tools that track Cumberland Pharmaceuticals Inc. performanceTreasury Yields & Weekly Market Pulse Updates - newser.com
Why Cumberland Pharmaceuticals Inc. stock is trending among retail tradersPortfolio Return Report & Fast Gain Stock Trading Tips - newser.com
Heatmap analysis for Cumberland Pharmaceuticals Inc. and competitors2025 Trading Volume Trends & Daily Stock Trend Watchlist - newser.com
Published on: 2025-11-03 00:44:08 - newser.com
Cumberland Pharmaceuticals Inc. stock outlook for YEARLayoff News & Verified Momentum Stock Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. a candidate for recovery play2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Is Cumberland Pharmaceuticals Inc. forming a reversal patternBull Run & Safe Capital Growth Stock Tips - newser.com
Can Cumberland Pharmaceuticals Inc. stock sustain institutional interest2025 Market Outlook & High Yield Stock Recommendations - newser.com
Is Cumberland Pharmaceuticals Inc. stock trading near support levelsQuarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Applying chart zones and confluence areas to Cumberland Pharmaceuticals Inc.Weekly Trading Summary & AI Enhanced Trading Signals - newser.com
Regression analysis insights on Cumberland Pharmaceuticals Inc. performance2025 Big Picture & Fast Gain Swing Alerts - newser.com
Cumberland Pharmaceuticals’ Promising Phase II Study on Ifetroban for IPF - MSN
Cumberland Pharmaceuticals (Nasdaq: CPIX) to Report Q3 2025 Results, Hosting Investor Call - Stock Titan
Will Cumberland Pharmaceuticals Inc. stock maintain growth storyEarnings Trend Report & Accurate Intraday Trade Tips - fcp.pa.gov.br
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE - Sahm
How moving averages guide Cumberland Pharmaceuticals Inc. tradingJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
What insider trading reveals about Cumberland Pharmaceuticals Inc. stockWeekly Investment Summary & Growth Oriented Trading Recommendations - fcp.pa.gov.br
Published on: 2025-10-27 22:22:34 - newser.com
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.35%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):